SILONasdaqPharmaceutical Preparations

Silo Pharma, Inc. (SILO) earnings date, market-implied expected move, and options open interest by expiry

1.21

−0.12 · −9.02%

Regular session10:54 ET

Open1.39Volume18,431Mkt cap$1.5M

Day1.21 – 1.390%52-wk1.10 – 10.431%

SILO

Silo Pharma, Inc.

OpenVolumeMkt capP/EEPSDiv yield

Day – 52-wk –

Expected move

No implied move.

Expected move

Inputs

Next report

Nov 12

in 7 days

est.Q3 FY26

Calendar

Next report

Last report

—

Largest filed tie

—

13F top-10 QoQ

−85.19%

shares held · 6 largest managers

13F · Jun 30 '26128d lag

Top fund weight

—

Silo Pharma (SILO) is expected to report on Nov 12 (estimated date).

Implied vs realized

No reported quarters.

Implied vs realized

Positioning

No open-interest data.

Positioning

Linked exposure

No linked exposure.

Linked exposure

Revenue flow

as filedQ2 FY26

−632.57%as filednet margin · revenue +132.02% QoQ · +105.94% YoY

Revenue$131,657+132.02%

Pre-tax income−$832,829+49.44%

Net income−$832,829−632.57%+49.44%

Tax$0—

Source: SEC filings · standardized · QE Jun 30 '26 · bars = % of revenue

Revenue flow

Intraday

15m bars

Hatch = extended hours · ▯ up · ▮ downSource: market data · 10:45 ET

Intraday

Event sensitivity

PCE ×1.02· ±4.7% vs ±4.6% · 19 releases

eventrelease day|move|up · n×base

PCEpersonal income & outlays±4.7%5 of 19×1.02

CPROFcorporate profits±4.6%3 of 12×1.02

NFPjobs report±4.1%2 of 10×0.90

GDPgross domestic product±3.7%4 of 19×0.82

CPIconsumer prices±3.7%3 of 10×0.80

FOMCrate decision±3.3%8 of 24×0.72

PPIproducer prices±3.2%4 of 10×0.70

Bar = avg |move| to ±5% · tick = ±4.6% avg day · ×base = |move| ÷ ±4.6% · min 6 releases

Earnings history

EPS -0.76 · consensus —

Quarter	Reported	EPS	Consensus
Q2 FY26	—	-0.76	—
Q1 FY26	—	-0.12	—
Q3 FY25	—	-0.12	—

Source: filed financials

Methodology

ties · implied moves · holdersMethod